Chennai Institute Of Neurosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 29.27%
- Profit Growth -29.62%
- Ebitda 59.27%
- Net Worth 27.50%
- Total Assets 34.30%
About Chennai Institute Of Neurosciences
Chennai Institute Of Neurosciences Private Limited (CIONPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 September 2002 and has a history of 22 years and five months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arjundas Deepak and Arjundas Deepak serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110TN2002PTC049640
- Company No.
049640
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Chennai Institute Of Neurosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjundas Deepak  | Additional Director | 28-Nov-2023 | Current |
| Arjundas Deepak | Director | 24-Sep-2002 | Current |
Financial Performance of Chennai Institute Of Neurosciences.
Chennai Institute Of Neurosciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 29.27% increase. The company also saw a substantial fall in profitability, with a 29.62% decrease in profit. The company's net worth Soared by an impressive increase of 27.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chennai Institute Of Neurosciences?
In 2017, Chennai Institute Of Neurosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chennai Institute Of Neurosciences?
Unlock and access historical data on people associated with Chennai Institute Of Neurosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chennai Institute Of Neurosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chennai Institute Of Neurosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
